These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 35964881)

  • 21. Benign prostatic hyperplasia: prostatic arterial embolization versus transurethral resection of the prostate--a prospective, randomized, and controlled clinical trial.
    Gao YA; Huang Y; Zhang R; Yang YD; Zhang Q; Hou M; Wang Y
    Radiology; 2014 Mar; 270(3):920-8. PubMed ID: 24475799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comprehensive analysis of clinical, quality of life, and cost-effectiveness outcomes of key treatment options for benign prostatic hyperplasia.
    Chughtai B; Rojanasarot S; Neeser K; Gultyaev D; Fu S; Bhattacharyya SK; El-Arabi AM; Cutone BJ; McVary KT
    PLoS One; 2022; 17(4):e0266824. PubMed ID: 35427376
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostatic artery embolization compared to transurethral resection of the prostate and prostatic urethral lift: a real-world population-based study.
    Raizenne BL; Zheng X; Oumedjbeur K; Mao J; Zorn KC; Elterman D; Bhojani N; McClure T; Te A; Kaplan S; Sedrakyan A; Chughtai B
    World J Urol; 2023 Jan; 41(1):179-188. PubMed ID: 36463348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-hospital cost analysis of prostatic artery embolization compared with transurethral resection of the prostate: post hoc analysis of a randomized controlled trial.
    Müllhaupt G; Hechelhammer L; Engeler DS; Güsewell S; Betschart P; Zumstein V; Kessler TM; Schmid HP; Mordasini L; Abt D
    BJU Int; 2019 Jun; 123(6):1055-1060. PubMed ID: 30578705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative efficacy and safety of prostatic urethral lift vs prostatic artery embolization for benign prostatic hyperplasia: a systematic review and network meta-analysis.
    Lucas-Cava V; Sánchez-Margallo FM; Insausti-Gorbea I; Sun F
    BJU Int; 2023 Feb; 131(2):139-152. PubMed ID: 35417622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The long-term cost effectiveness of treatments for benign prostatic hyperplasia.
    DiSantostefano RL; Biddle AK; Lavelle JP
    Pharmacoeconomics; 2006; 24(2):171-91. PubMed ID: 16460137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostatic Artery Embolization (PAE) and Transurethral Resection of the Prostate (TURP) have a Differential Impact on Lower Urinary Tract Symptoms (LUTS): Retrospective Analysis of the Multicentre UK-ROPE (UK Register of Prostate Embolization) Study.
    Vigneswaran G; Maclean D; Hadi M; Maher B; Modi S; Bryant T; Harris M; Hacking N
    Cardiovasc Intervent Radiol; 2021 Jul; 44(7):1095-1102. PubMed ID: 33825062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of prostatic artery embolization for benign prostatic hyperplasia: a systematic review and meta-analysis of randomized controlled trials.
    Xiang P; Guan D; Du Z; Hao Y; Yan W; Wang Y; Liu Y; Liu D; Ping H
    Eur Radiol; 2021 Jul; 31(7):4929-4946. PubMed ID: 33449181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostatic artery embolization in benign prostatic hyperplasia: preliminary results in 13 patients.
    Grosso M; Balderi A; Arnò M; Sortino D; Antonietti A; Pedrazzini F; Giovinazzo G; Vinay C; Maugeri O; Ambruosi C; Arena G
    Radiol Med; 2015 Apr; 120(4):361-8. PubMed ID: 25245496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostatic artery embolization versus conventional TUR-P in the treatment of benign prostatic hyperplasia: protocol for a prospective randomized non-inferiority trial.
    Abt D; Mordasini L; Hechelhammer L; Kessler TM; Schmid HP; Engeler DS
    BMC Urol; 2014 Nov; 14():94. PubMed ID: 25425136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostatic Artery Embolization for the Treatment of Recurrent Lower Urinary Tract Symptoms following Transurethral Resection of the Prostate.
    Xu ZW; Tian W; Zhou CG; Leng B; Shi HB; Liu S
    J Vasc Interv Radiol; 2021 Feb; 32(2):242-246. PubMed ID: 33248915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A cost-minimisation analysis comparing photoselective vaporisation (PVP) and transurethral resection of the prostate (TURP) for the management of symptomatic benign prostatic hyperplasia (BPH) in Queensland, Australia.
    Whitty JA; Crosland P; Hewson K; Narula R; Nathan TR; Campbell PA; Keller A; Scuffham PA
    BJU Int; 2014 Mar; 113 Suppl 2():21-8. PubMed ID: 23574626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostatic arterial embolisation for men with benign prostatic hyperplasia: a Cochrane review.
    Jung JH; McCutcheon KA; Borofsky M; Young S; Golzarian J; Kim MH; Narayan V; Dahm P
    BJU Int; 2023 Jan; 131(1):32-45. PubMed ID: 35696302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Photovaporization of the prostate with GreenLight™ laser 180 W XPS versus transurethral resection of the prostate with monopolar energy for the treatment of benign prostatic enlargement: a cost-utility analysis from a healthcare perspective.
    Caicedo JI; Taborda A; Robledo D; Bravo-Balado A; Domínguez C; Trujillo CG; Cataño JG; Campos Hernández J; Londoño Trujillo D; Plata M
    World J Urol; 2019 May; 37(5):861-866. PubMed ID: 30116964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost effectiveness of microwave thermotherapy in patients with benign prostatic hyperplasia: part II--results.
    Blute M; Ackerman SJ; Rein AL; Beusterien K; Sullivan EM; Tanio CP; Strauss MJ; Manyak MJ
    Urology; 2000 Dec; 56(6):981-7. PubMed ID: 11113744
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The STREAM Trial (Prostatic Artery Embolization for the Treatment of Benign Prostatic Hyperplasia) 24-Month Clinical and Radiological Outcomes.
    Tapping CR; Little MW; Macdonald A; Mackinnon T; Kearns D; Macpherson R; Crew J; Boardman P
    Cardiovasc Intervent Radiol; 2021 Mar; 44(3):436-442. PubMed ID: 33210152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cost-effectiveness of transurethral resection of the prostate vs thulium laser transurethral vaporesection of the prostate in the UNBLOCS randomised controlled trial for benign prostatic obstruction.
    Noble SM; Ahern AM; Worthington J; Hashim H; Taylor H; Young GJ; Brookes S; Abrams P; Johnson L; Khan R; Page T; Swami KS; Lane JA
    BJU Int; 2020 Nov; 126(5):595-603. PubMed ID: 32558178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two-year Outcomes after Transurethral Prostate Resection Post-prostatic Artery Embolization Versus Transurethral Prostate Resection Alone For Giant Benign Prostatic Hyperplasia.
    Zhiyu Z; Zhen S; Qi Z; Yuhua H; Jun O; Xuefeng Z
    Urol J; 2023 Oct; 20(5):361-368. PubMed ID: 37634068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Introduction of prostate artery embolization (PAE) in Sweden.
    Lindgren H; Bläckberg M
    Scand J Urol; 2019; 53(2-3):151-155. PubMed ID: 31096824
    [No Abstract]   [Full Text] [Related]  

  • 40. Prostatic artery embolization versus transurethral resection of the prostate in management of benign prostatic hyperplasia.
    Radwan A; Farouk A; Higazy A; Samir YR; Tawfeek AM; Gamal MA
    Prostate Int; 2020 Sep; 8(3):130-133. PubMed ID: 33102395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.